Skip to main content

Table 2 The effects of the changes in biochemical markers on DM patients

From: Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report

 

Before administration

24 weeks after treatment

p

BNP

39.2 ± 10.8

33.6 ± 10.4*

0.048

hsCRP

1859.5 ±426.7

2600.2 ± 745.9

0.254

HMW adiponectin

3.58 ± 0.43

3.82 ±0.53

0.468

PTX3

2.39 ± 0.26

2.16 ±0.29

0.082

IL-1β

2.23 ± 7.66

2.57 ±8.91

0.297

IL-6

3.62 ± 8.90

3.69 ±9.18

0.879

TNF-α

4.34 ±2.00

4.38 ± 1.17

0.872

MCP-1

554.78 ±204.55

565.88 ± 211.85

0.581

IFN-γ

3.94 ± 5.52

3.97 ± 4.75

0.9419

  1. BNP: brain natriuretic peptide, hs CRP: high-sensitive C-reactive protein, HMW: high molecular weight, PTX3 pentraxin-3, IL: interleukin, MCP-1: monocyte chemoattractant protein-1, IFN: interferon.
  2. *p<0.05 vs before treatment.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840